Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Olmesartan Medoxomil Impurity 39

Olmesartan Medoxomil Impurity 39 is listed in the pharmaceutical impurity collection under CAS 144690-07-3. Its represented structure has formula C11H16N2O3 and a calculated molecular weight of 224.26 g/mol.

2D chemical structure

N O O O N H

Chemical identity

Catalog name
Olmesartan Medoxomil Impurity 39
Common name
Olmesartan Medoxomil Impurity 39
Chemical name
ethyl 4-acetyl-2-propyl-1H-imidazole-5-carboxylate
CAS
144690-07-3
SMILES
CCCc1nc(C(C)=O)c(C(=O)OCC)[nH]1
InChI
InChI=1S/C11H16N2O3/c1-4-6-8-12-9(7(3)14)10(13-8)11(15)16-5-2/h4-6H2,1-3H3,(H,12,13)
InChIKey
VZPSJLSTXDBKLC-UHFFFAOYSA-N
Associated API
Olmesartan Medoxomil

Record ID: A9309af58e3d3

Computed properties

C11H16N2O3 Molecular formula
224.26 g/molMolecular weight
224.1161 DaMonoisotopic exact mass
72.05 ŲTopological polar surface area
1.7415 Calculated LogP (Wildman–Crippen)
58.5437 cm³/molMolar refractivity (Wildman–Crippen)
4 countHydrogen-bond acceptors
1 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H N O 0 4 8 12 16 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight224.2623.67
Calculated LogP (Wildman–Crippen)1.741537.63
Topological polar surface area72.0551.19
Hydrogen-bond acceptors450.68
Hydrogen-bond donors138.08
Rotatable bonds (strict)560.59

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC11H16N2O3dimensionless
Molecular weight224.26g/mol
Monoisotopic exact mass224.1161Da
Topological polar surface area72.05Ų
Calculated LogP (Wildman–Crippen)1.7415dimensionless
Molar refractivity (Wildman–Crippen)58.5437cm³/mol
Hydrogen-bond acceptors4count
Hydrogen-bond donors1count
Rotatable bonds (strict)5count
Heavy atoms16count
Heteroatoms5count
Rings1count
Aromatic rings1count
Aliphatic rings0count
Saturated rings0count
Aromatic heterocycles1count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles0count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.5455fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area94.2163Ų
Valence electrons88count
Radical electrons0count
Bertz complexity395.934index
Balaban J3.0426index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Olmesartan Medoxomil Impurity 39

Qualification and safety assessment of Olmesartan Medoxomil Impurity 39

Explore toxicological qualification of Olmesartan Medoxomil Impurity 39 and ICH M7 mutagenic impurity assessment of Olmesartan Medoxomil Impurity 39 for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Olmesartan Medoxomil Impurity 39 and acceptable intake and limit justification for Olmesartan Medoxomil Impurity 39. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Olmesartan Medoxomil Impurity 39

Explore Altox services and software through the Altox Pharma-Hub.